Attorney Mark Lanier, founder of The Lanier Law Firm, and Tammy Tran of Houston’s The Tammy Tran Law Firm are representing Anna Pham and her mother Natalie Pham in their claims against Toyota Motor Corp. and Auto Spot, the Houston-area dealership where the car was purchased. Anna Pham suffered chest injuries, back injuries, and significant lacerations in the crash while driving her mother’s 2008 Toyota Camry SE. The case is Natalie Pham and Anna Pham v. Toyota Motor Corp., et al., No. 201013919.
“Our clients are victims of Toyota’s mistakes,” says Mr. Lanier. “Our goal is to make sure Toyota is held accountable.
The Lanier Law Firm is handling more than 300 cases against Toyota for clients in California, New York and Texas. Mr. Lanier has served as a national commentator on Toyota’s problems on both CNBC’s “Squawkbox” and Fox Business Network’s “Varney & Company,” where he stated “Juries tend to penalize corporations when they place profits ahead of the consumer’s safety.” His views also have been featured in a commentary published by FOX News.
Toyota has recalled more than 8.5 million vehicles covering 17 different models, including recalls based on unexpected acceleration, faulty floor mats, brake problems, drive shaft malfunctions, and other problems. The National Highway Traffic Safety Administration has recorded 34 deaths attributed to unintended acceleration in Toyota vehicles.
Mr. Lanier says Toyota has not responded to his call for an investigation of whether the recalls are a process problem, such as malfunctioning electronics, rather than a parts problem like faulty floor mats.
“There are a lot of the same issues in this case,” says Mr. Lanier. “We have a company that knew it had a problem and did little to nothing to fix it while customers suffer the consequences.”
The Lanier Law Firm has served as lead counsel in some of the most significant product liability trials in U.S. history, including the national litigation over the painkiller Vioxx. The firm’s work in the nation’s first Vioxx trial resulted in a $254 million verdict, and paved the way for a multi-billion-dollar settlement of all U.S. Vioxx claims.